A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|14 May 2014||Submitted||Original manuscript|
|14 May 2014||Author responded||Author comments - Lars Pape|
|Resubmission - Version 2|
|14 May 2014||Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|15 May 2014||Author responded||Author comments - Lars Pape|
|Resubmission - Version 5|
|15 May 2014||Submitted||Manuscript version 5|
|23 Jun 2014||Reviewed||Reviewer Report - John Norrie|
|10 Jul 2014||Author responded||Author comments - Lars Pape|
|Resubmission - Version 6|
|10 Jul 2014||Submitted||Manuscript version 6|
|4 Aug 2014||Editorially accepted|
|15 Aug 2014||Article published||10.1186/1745-6215-15-324|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.